Clinical Trials
3 trialsNCT04745975 2022-04-20
Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer
Fudan University
Phase 2 Unknown
NCT03521245 2021-09-14
Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
OmicsWay Corp.
Unknown
NCT03724097 2021-09-14
Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy
OmicsWay Corp.
Unknown